{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:36:43Z","timestamp":1788295003461,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.annder.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T01:01:19Z","timestamp":1638925279000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rosacea: Treatment targets based on new physiopathology data"],"prefix":"10.1016","volume":"149","author":[{"given":"B.","family":"Cribier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2021.11.001_bib0570","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjd.17590","article-title":"Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments","volume":"181","author":"van Zuuren","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0575","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.annder.2021.11.001_bib0580","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0585","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0590","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000339478","article-title":"Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses","volume":"224","author":"Peuvrel","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2021.11.001_bib0595","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/09546634.2019.1580669","article-title":"A decade retrospective study of light\/laser devices in treating nasal rosacea","volume":"31","author":"Zhang","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.annder.2021.11.001_bib0600","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14764172.2018.1528371","article-title":"Comparative efficacy of short-pulsed intense pulsed light and pulsed dye laser to treat rosacea","volume":"21","author":"Kim","year":"2019","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0605","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14764172.2020.1717540","article-title":"Short pulse intense pulsed light versus pulsed dye laser for the treatment of facial redness","volume":"22","author":"Tirico","year":"2020","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0610","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s13555-020-00440-5","article-title":"Retrospective Study of Factors Affecting Efficacy of Therapy with Dye Pulsed Light for Erythematotelangiectatic Rosacea","volume":"10","author":"Zhao","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2021.11.001_bib0615","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/14764172.2017.1418510","article-title":"Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia","volume":"20","author":"Kwon","year":"2018","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0620","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10103-017-2410-8","article-title":"Long-pulsed 1064-nm Nd: YAG laser ameliorates LL-37-induced rosacea-like skin lesions through promoting collagen remodeling in BALB\/c mice","volume":"33","author":"Kim","year":"2018","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.annder.2021.11.001_bib0625","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pdpdt.2018.08.005","article-title":"Photodynamic therapy for rosacea in Chinese patients","volume":"24","author":"Fan","year":"2018","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0630","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/jocd.12231","article-title":"Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea","volume":"15","author":"Friedmann","year":"2016","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0635","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3889\/oamjms.2019.536","article-title":"Rosacea flare - Up after photodynamic therapy (PDT) for field cancerization and a review on adverse events with PDT in general","volume":"7","author":"Wollina","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.annder.2021.11.001_bib0640","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09546634.2019.1639606","article-title":"Difference in vasoconstrictors: oxymetazoline vs. brimonidine","volume":"32","author":"Okwundu","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2021.11.001_bib0645","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/exd.13381","article-title":"Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel","volume":"26","author":"Kim","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0650","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/exd.13793","article-title":"Brimonidine displays anti-inflammatory properties in the skin through the modulation of the vascular barrier function","volume":"27","author":"Bertino","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0655","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s12325-016-0404-8","article-title":"Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy","volume":"33","author":"Docherty","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0660","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1203475418789020","article-title":"Case Report: Allergic Contact Dermatitis to Topical Brimonidine Demonstrated With Patch Testing: Insights on Evaluation of Brimonidine Sensitization","volume":"22","author":"Ringuet","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.annder.2021.11.001_bib0665","first-page":"692","article-title":"Fifteen Minute Test May Save 15% or More on Rosacea Treatment","volume":"17","author":"Darwin","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0670","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.17865","article-title":"New evidence but still unmet medical needs in rosacea treatment","volume":"181","author":"Le Cleach","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0675","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s13555-019-00322-5","article-title":"Erythema of Rosacea Affects Health-Related Quality of Life: Results of a Survey Conducted in Collaboration with the National Rosacea Society","volume":"9","author":"Baldwin","year":"2019","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2021.11.001_bib0680","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1523-1747.ep12524458","article-title":"Oral thermal-induced flushing in erythematotelangiectatic rosacea","volume":"76","author":"Wilkin","year":"1981","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0685","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-95-4-468","article-title":"Flushing reactions: consequences and mechanisms","volume":"95","author":"Wilkin","year":"1981","journal-title":"Ann Intern Med"},{"issue":"Suppl 6","key":"10.1016\/j.annder.2021.11.001_bib0690","first-page":"38","article-title":"Physical modalities for the treatment of rosacea","volume":"14","author":"Hofmann","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2021.11.001_bib0695","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archderm.143.11.1369","article-title":"Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline","volume":"143","author":"Shanler","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0700","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/17512433.2014.945910","article-title":"Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea","volume":"7","author":"Tong","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.annder.2021.11.001_bib0705","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamadermatol.2019.3508","article-title":"Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals: A Randomized Clinical Trial","volume":"156","author":"Yu","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0710","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archderm.1983.01650270029012","article-title":"Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions","volume":"119","author":"Wilkin","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0715","first-page":"729","article-title":"Traitement de la rosac\u00e9e. Clonidine (0,075mg\/j) versus placebo (r\u00e9sultats pr\u00e9liminaires)","volume":"124","author":"Van Landuyt","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0720","first-page":"687","article-title":"Rilm\u00e9nidine dans la rosac\u00e9e: \u00e9tude en double insu contre placebo [Rilmenidine in rosacea: a double-blind study versus placebo]","volume":"124","author":"Grosshans","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0725","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaad.2020.04.129","article-title":"Use of beta-blockers for rosacea-associated facial erythema and flushing: a systematic review and update on proposed mode of action","volume":"83","author":"Logger","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0730","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1346-8138.12687","article-title":"Propranolol, doxycycline and combination therapy for the treatment of rosacea","volume":"42","author":"Park","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0735","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","article-title":"Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective \u03b2-adrenergic blocker","volume":"67","author":"Hsu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0740","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/09546634.2017.1360991","article-title":"Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol","volume":"29","author":"Pietschke","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2021.11.001_bib0745","doi-asserted-by":"crossref","first-page":"e14520","DOI":"10.1111\/dth.14520","article-title":"Facial flushing and erythema of rosacea improved by carvedilol","volume":"33","author":"Seo","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0750","first-page":"22","article-title":"Efficacy of Topical Timolol 0.5% in the Treatment of Acne and Rosacea: A Multicentric Study","volume":"13","author":"Al Mokadem","year":"2020","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0755","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DSS.0000000000001819","article-title":"Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema","volume":"45","author":"Kim","year":"2019","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.annder.2021.11.001_bib0760","first-page":"549","article-title":"A Pilot, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of IncobotulinumtoxinA Injections in the Treatment of Rosacea","volume":"16","author":"Dayan","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0765","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/lsm.23023","article-title":"The toxic edge-A novel treatment for refractory erythema and flushing of rosacea","volume":"51","author":"Friedman","year":"2019","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.annder.2021.11.001_bib0770","doi-asserted-by":"crossref","first-page":"13976","DOI":"10.1111\/dth.13976","article-title":"Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing","volume":"33","author":"Al-Niaimi","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib0775","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jid.2019.08.436","article-title":"Innate Immune Dysfunction in Rosacea Promotes Photosensitivity and Vascular Adhesion Molecule Expression","volume":"140","author":"Kulkarni","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0780","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0785","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0790","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdermsci.2020.08.011","article-title":"TLR3 augments glucocorticoid-synthetic enzymes expression in epidermal keratinocytes; Implications of glucocorticoid metabolism in rosacea epidermis","volume":"100","author":"Shimada-Omori","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.annder.2021.11.001_bib0795","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/09273948.2018.1504971","article-title":"Elevated Tear Human Neutrophil Peptides 1-3, Human Beta Defensin-2 Levels and Conjunctival Cathelicidin LL-37 Gene Expression in Ocular Rosacea","volume":"27","author":"G\u00f6k\u00e7\u0131nar","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.annder.2021.11.001_bib0800","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/jid.2012.14","article-title":"Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin","volume":"132","author":"Kanada","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0805","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/jid.2013.472","article-title":"Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor","volume":"134","author":"Two","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0810","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fmed.2019.00324","article-title":"The Theranostics Role of Mast Cells in the Pathophysiology of Rosacea","volume":"6","author":"Wang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.annder.2021.11.001_bib0815","first-page":"1","article-title":"Combination of ultra-low-dose isotretinoin and antihistamines in treating Morbihan disease - a new long-term approach with excellent results and a minimum of side effects","author":"Welsch","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2021.11.001_bib0820","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2340\/00015555-3168","article-title":"Morbihan Syndrome Successfully Treated with Omalizumab","volume":"99","author":"Kafi","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0825","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdermsci.2018.12.004","article-title":"Botulinum toxin blocks mast cells and prevents rosacea like inflammation","volume":"93","author":"Choi","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.annder.2021.11.001_bib0830","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2340\/00015555-2335","article-title":"Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options","volume":"96","author":"Steinhoff","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0835","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archdermatol.2010.413","article-title":"Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment","volume":"147","author":"Scharschmidt","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0840","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/1346-8138.15629","article-title":"Neurogenic rosacea in Korea","volume":"48","author":"Kim","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0845","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/archderm.140.11.1345","article-title":"Laser treatment of rosacea: a pathoetiological study","volume":"140","author":"Lonne-Rahm","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0850","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clindermatol.2016.10.017","article-title":"Cosmeceuticals for rosacea","volume":"35","author":"Draelos","year":"2017","journal-title":"Clin Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.annder.2021.11.001_bib0855","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jdv.13532","article-title":"Sensitive skin","volume":"30","author":"Misery","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0860","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaad.2017.03.040","article-title":"Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis","volume":"77","author":"Chang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0865","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s13555-020-00458-9","article-title":"The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?","volume":"10","author":"Forton","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2021.11.001_bib0870","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/jdv.13801","article-title":"Efficacy and safety of permethrin 5% topical gel vs. placebo for rosacea: a double-blind randomized controlled clinical trial","volume":"30","author":"Raoufinejad","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0875","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0880","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1099\/jmm.0.065136-0","article-title":"Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients","volume":"63","author":"Jarmuda","year":"2014","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.annder.2021.11.001_bib0885","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micpath.2014.04.002","article-title":"Microbiota of Demodex mites from rosacea patients and controls","volume":"71\u201372","author":"Murillo","year":"2014","journal-title":"Microb Pathog"},{"key":"10.1016\/j.annder.2021.11.001_bib0890","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13555-018-0249-y","article-title":"Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations","volume":"8","author":"Ebbelaar","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2021.11.001_bib0895","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/jdv.14437","article-title":"Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea","volume":"31","author":"Schaller","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0900","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/jdv.14084","article-title":"Monitoring structural changes in Demodex mites under topical Ivermectin in rosacea by means of reflectance confocal microscopy: a case series","volume":"31","author":"Ruini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0905","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jdv.15938","article-title":"Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms","volume":"34","author":"Forton","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0910","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/microorganisms8111756","article-title":"Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea-A Systematic Review of the Literature","volume":"8","author":"Tutka","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.annder.2021.11.001_bib0915","article-title":"Comparison of the skin microbiota in acne and rosacea","author":"Thompson","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0920","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/jcm9010185","article-title":"Characterization and Analysis of the Skin Microbiota in Rosacea: Impact of Systemic Antibiotics","volume":"9","author":"Woo","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.annder.2021.11.001_bib0925","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/exd.13491","article-title":"Characterization of the facial microbiome in twins discordant for rosacea","volume":"27","author":"Zaidi","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0930","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/exd.13398","article-title":"Rosacea and its association with enteral microbiota in Korean females","volume":"27","author":"Nam","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-020-00460-1","article-title":"Rosacea and the microbiome: A systematic review","volume":"11","author":"Daou","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2021.11.001_bib0940","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/exd.14016","article-title":"Targeting the gut-skin axis-Probiotics as new tools for skin disorder management?","volume":"28","author":"Sz\u00e1nt\u00f3","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0945","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jid.2020.02.025","article-title":"Rosacea Is Characterized by a Profoundly Diminished Skin Barrier","volume":"140","author":"Medgyesi","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0950","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/1346-8138.14792","article-title":"Claudin reduction may relate to an impaired skin barrier in rosacea","volume":"46","author":"Deng","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0955","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/srt.12318","article-title":"Clinical assessment of rosacea severity: oriental score vs. quantitative assessment method with imaging and biomedical tools","volume":"23","author":"Kim","year":"2017","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.annder.2021.11.001_bib0960","doi-asserted-by":"crossref","first-page":"e23363","DOI":"10.1002\/jcla.23363","article-title":"Rosacea is associated with conjoined interactions between physical barrier of the skin and microorganisms: A pilot study","volume":"34","author":"Yuan","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.annder.2021.11.001_bib0965","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/jidsymp.2011.2","article-title":"Epidermal proteases in the pathogenesis of rosacea","volume":"15","author":"Meyer-Hoffert","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.annder.2021.11.001_bib0970","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjd.12770","article-title":"Epidermal hydration levels in patients with rosacea improve after minocycline therapy","volume":"171","author":"N\u00ed Raghallaigh","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0975","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2133.2011.10662.x","article-title":"The fatty acid profile of the skin surface lipid layer in papulopustular rosacea","volume":"166","author":"N\u00ed Raghallaigh","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0980","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jid.2016.12.025","article-title":"Sebaceous Gland-Rich Skin Is Characterized by TSLP Expression and Distinct Immune Surveillance Which Is Disturbed in Rosacea","volume":"137","author":"Dajnoki","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0985","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1111\/jdv.16055","article-title":"Sebaceous glands participate in the inflammation of rosacea","volume":"34","author":"Lee","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib0990","first-page":"420","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib0995","first-page":"1","article-title":"The Pro-Differentiation Effect of Doxycycline on Human SZ95 Sebocytes","author":"Zouboulis","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2021.11.001_bib1000","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ddg.14247","article-title":"Evaluation of the efficacy of subantimicrobial dose doxycycline in rosacea: a systematic review of clinical trials and meta-analysis","volume":"19","author":"Husein-ElAhmed","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2021.11.001_bib1005","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jid.2016.01.025","article-title":"A randomized-controlled trial of oral low-dose isotretinoin for difficult-to-treat papulopustular rosacea","volume":"136","author":"Sbidian","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1010","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2012.111","article-title":"Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients","volume":"132","author":"Dispenza","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1015","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0190-9622(00)90220-2","article-title":"The clinicopathologic spectrum of rhinophyma","volume":"42","author":"Aloi","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/cup.12518","article-title":"Histopathology of rhinophyma - a clinical-histopathologic correlation","volume":"42","author":"Sch\u00fc\u00fcrmann","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2021.11.001_bib1025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000637-200045050-00008","article-title":"Overexpression of transforming growth factor beta-2 and its receptor in rhinophyma: an alternative mechanism of pathobiology","volume":"45","author":"Pu","year":"2000","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.annder.2021.11.001_bib1030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2018.12.046","article-title":"Rhinophyma is associated with alcohol intake","volume":"81","author":"Second","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1035","doi-asserted-by":"crossref","first-page":"110097","DOI":"10.1016\/j.mehy.2020.110097","article-title":"A hypothesis: Role of physical factors in pathophysiology of rhinophyma - Focus on habitual mechanical trauma","volume":"143","author":"Borz\u0119cki","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.annder.2021.11.001_bib1040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1468-3083.2006.01474.x","article-title":"Rhinophyma in an adolescent","volume":"20","author":"Bittencourt","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib1045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00105-018-4162-1","article-title":"Therapieerfolg mit niedrig dosiertem systemischem Isotretinoin","volume":"69","author":"Pohl","year":"2018","journal-title":"Hautarzt"},{"key":"10.1016\/j.annder.2021.11.001_bib1050","doi-asserted-by":"crossref","DOI":"10.1007\/s10103-020-03183-z","article-title":"Rhinophyma in women: a case series","author":"Ismail","year":"2021","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.annder.2021.11.001_bib1055","first-page":"1","article-title":"Combination of ultra-low-dose isotretinoin and antihistamines in treating Morbihan disease - a new long-term approach with excellent results and a minimum of side effects","author":"Welsch","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2021.11.001_bib1060","first-page":"32","article-title":"Effective treatment of Morbihan's disease with long-term isotretinoin: A report of three cases","volume":"12","author":"Olvera-Cort\u00e9s","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1065","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archdermatol.2012.3109","article-title":"Successful long-term use of oral isotretinoin for the management of Morbihan disease: a case series report and review of the literature","volume":"148","author":"Smith","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1070","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/jcm9103336","article-title":"Systemic comorbidities in Korean patients with rosacea: results from a multi-institutional case-control study","volume":"9","author":"Woo","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.annder.2021.11.001_bib1075","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2015.2230","article-title":"Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins","volume":"151","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1080","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaad.2017.02.040","article-title":"Alcohol intake and risk of rosacea in US women","volume":"76","author":"Li","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1085","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamadermatol.2018.3301","article-title":"Association of caffeine intake and caffeinated coffee consumption with risk of incident rosacea in women","volume":"154","author":"Li","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1090","first-page":"e14747","article-title":"Association between rosacea and smoking: A systematic review and meta-analysis","author":"Yuan","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.11.001_bib1095","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/jdv.16595","article-title":"Cigarette smoking and risk of rosacea: a nationwide population-based cohort study","volume":"34","author":"Dai","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib1100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kwx054","article-title":"Cigarette Smoking and Risk of Incident Rosacea in Women","volume":"186","author":"Li","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annder.2021.11.001_bib1105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jid.2019.08.436","article-title":"Innate immune dysfunction in rosacea promotes photosensitivity and vascular adhesion molecule expression","volume":"140","author":"Kulkarni","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdermsci.2014.09.002","article-title":"Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea","volume":"76","author":"Salzer","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.annder.2021.11.001_bib1115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/exd.13702","article-title":"Increased expression of IL-33 in rosacea skin and UVB-irradiated and LL-37-treated HaCaT cells","volume":"27","author":"Suhng","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2009.04.024","article-title":"Papulopustular rosacea: prevalence and relationship to photodamage","volume":"63","author":"McAleer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.11.001_bib1125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-2220","article-title":"Rosacea: The Blessing of the Celts - An Approach to Pathogenesis Through Translational Research","volume":"96","author":"Melnik","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2021.11.001_bib1130","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.14020","article-title":"Impact of ultraviolet radiation and exposome on rosacea. Key role of photoprotection in optimizing treatment","author":"Morgado-Carrasco","year":"2021","journal-title":"J Cosmet Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:41Z","timestamp":1758971441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963821000983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0151963821000983"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2021.11.001","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosacea: Treatment targets based on new physiopathology data","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}